Detalhe da pesquisa
1.
Efficacy and safety of dulaglutide compared with glargine in patients with type 2 diabetes: A systematic review and meta-analysis.
J Clin Pharm Ther
; 46(5): 1245-1253, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675117
2.
MiR-346 and TRAb as Predicative Factors for Relapse in Graves' Disease Within One Year.
Horm Metab Res
; 49(3): 180-184, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192819
3.
Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease.
Diabetes Metab Syndr Obes
; 15: 1749-1759, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706476
4.
CD47 is associated with the up-regulation of the PD-1 oncogenic signaling pathway.
Int J Clin Exp Pathol
; 11(12): 5612-5621, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949648
5.
Elevated Serum IL-17 Expression at Cessation Associated with Graves' Disease Relapse.
Int J Endocrinol
; 2018: 5689030, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713343